Statistical Considerations for the Development of a Novel Hierarchical Composite Endpoint for Broad CKD Trials
Time: 11:00 am
day: Day 1 Track 3 AM
Details:
- Identifying a novel HCE to provide a reasonable clinical sample size
- Outlining design considerations to establish this HCE as a primary endpoint to be used broadly across CKD trials
- Analysis and reporting considerations for the novel HCE (win statistics and maraca plots)
